Erik Ryberg
Impact in
- Pharmacology top 0.2%
- Cannabis and Cannabinoid Research
-
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
Papers in
-
- Cannabis and Cannabinoid Research 8
-
- Neuroscience and Neuropharmacology Research 4
- Neurotransmitter Receptor Influence on Behavior 4
- Neuroscience and Neural Engineering 1
- Co-authors
- Peter J. Greasley (8 shared papers)Stephan Hjorth (5 shared papers)Niklas Larsson (2 shared papers)Thomas Elebring (2 shared papers)Peter Nilsson (1 shared paper)S. Sjögren (1 shared paper)Tomáš Drmota (1 shared paper)Michael J. Rogers (1 shared paper)
- Journals
- Pharmacology Research & Perspectives (3 papers)FEBS Letters (2 papers)PLoS ONE (2 papers)Cardiovascular Drugs and Therapy (1 paper)Biochemical Journal (1 paper)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Erik Ryberg
14 papers receiving 1.9k citations
Erik Ryberg's Hit Papers
Peers
Comparison fields: 5 of 86
- Pharmacology 1.5k
- Cellular and Molecular Neuroscience 645
- Endocrine and Autonomic Systems 142
- Toxicology 73
- Endocrinology, Diabetes and Metabolism 278
Countries citing papers authored by Erik Ryberg
This map shows the geographic impact of Erik Ryberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Ryberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Ryberg more than expected).
Fields of papers citing papers by Erik Ryberg
This network shows the impact of papers produced by Erik Ryberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Ryberg. The network helps show where Erik Ryberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Ryberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The orphan receptor GPR55 is a novel cannabinoid receptor Hit paper breakdown → | 2007 | 1252 |
| 2 | 2009 | 258 | |
| 3 | 2004 | 110 | |
| 4 | 2011 | 48 | |
| 5 | 2013 | 47 | |
| 6 | 2015 | 46 | |
| 7 | 2019 | 34 | |
| 8 | 2016 | 28 | |
| 9 | 2009 | 25 | |
| 10 | 2015 | 21 | |
| 11 | 2020 | 13 | |
| 12 | 2018 | 11 | |
| 13 | 2022 | 6 | |
| 14 | 2025 | 4 | |
| 15 | 2018 | 0 |
About Erik Ryberg
Erik Ryberg is a scholar working on Pharmacology, Cellular and Molecular Neuroscience, Surgery, Molecular Biology and Physiology, having authored 15 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (8 papers), Neuroscience and Neuropharmacology Research (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers), Pancreatic function and diabetes (4 papers), Receptor Mechanisms and Signaling (2 papers), Diabetes Management and Research (1 paper), Neuroscience and Neural Engineering (1 paper) and Biochemical effects in animals (1 paper). The work is most often cited by research in Pharmacology (1.5k citations), Cellular and Molecular Neuroscience (645 citations), Endocrine and Autonomic Systems (142 citations), Toxicology (73 citations) and Endocrinology, Diabetes and Metabolism (278 citations). Erik Ryberg has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Peter J. Greasley, Stephan Hjorth, Niklas Larsson, Thomas Elebring, Peter Nilsson, S. Sjögren, Tomáš Drmota, Michael J. Rogers, Lauren S. Whyte and Natalie A. Sims. Their work appears in journals such as Pharmacology Research & Perspectives, FEBS Letters, PLoS ONE, Cardiovascular Drugs and Therapy and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.